pubmed-article:17356938 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0031150 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0001511 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0164209 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0024348 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0231491 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C0547047 | lld:lifeskim |
pubmed-article:17356938 | lifeskim:mentions | umls-concept:C1522492 | lld:lifeskim |
pubmed-article:17356938 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:17356938 | pubmed:dateCreated | 2007-9-13 | lld:pubmed |
pubmed-article:17356938 | pubmed:abstractText | Up to 94% of patients experience fibrous adhesions after abdominal surgery, and a significant number of these patients require a second operation for open or laparoscopic lysis of adhesions (LOA). The authors have previously shown that inhibition of the binding of tachykinin ligands to the neurokinin 1 receptor (NK-1R) using the neurokinin 1 receptor antagonist (NK-1RA) CJ-12,255 decreases primary adhesion formation and upregulates the peritoneal fibrinolytic system in a rat model. Whereas most studies have focused on the prevention of primary adhesions, few have addressed adhesion reformation after LOA. This study aimed to determine the effects of NK-1RA administration on adhesion reformation and peritoneal fibrinolytic activity after laparoscopic LOA. | lld:pubmed |
pubmed-article:17356938 | pubmed:language | eng | lld:pubmed |
pubmed-article:17356938 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17356938 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17356938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17356938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17356938 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17356938 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17356938 | pubmed:month | Oct | lld:pubmed |
pubmed-article:17356938 | pubmed:issn | 1432-2218 | lld:pubmed |
pubmed-article:17356938 | pubmed:author | pubmed-author:LeemanS ESE | lld:pubmed |
pubmed-article:17356938 | pubmed:author | pubmed-author:BeckerJ MJM | lld:pubmed |
pubmed-article:17356938 | pubmed:author | pubmed-author:ReedK LKL | lld:pubmed |
pubmed-article:17356938 | pubmed:author | pubmed-author:StucchiA FAF | lld:pubmed |
pubmed-article:17356938 | pubmed:author | pubmed-author:PrushikS GSG | lld:pubmed |
pubmed-article:17356938 | pubmed:author | pubmed-author:AaronsC BCB | lld:pubmed |
pubmed-article:17356938 | pubmed:author | pubmed-author:MatteottiRR | lld:pubmed |
pubmed-article:17356938 | pubmed:author | pubmed-author:GowerA CAC | lld:pubmed |
pubmed-article:17356938 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17356938 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:17356938 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17356938 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17356938 | pubmed:pagination | 1790-5 | lld:pubmed |
pubmed-article:17356938 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:meshHeading | pubmed-meshheading:17356938... | lld:pubmed |
pubmed-article:17356938 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17356938 | pubmed:articleTitle | A neurokinin 1 receptor antagonist decreases adhesion reformation after laparoscopic lysis of adhesions in a rat model of adhesion formation. | lld:pubmed |
pubmed-article:17356938 | pubmed:affiliation | Department of Surgery, Boston University School of Medicine, 88 East Newton street, C500, Boston, MA 02118, USA. scott.prushik@bmc.org | lld:pubmed |
pubmed-article:17356938 | pubmed:publicationType | Journal Article | lld:pubmed |